288 related articles for article (PubMed ID: 17108229)
1. Isolation and comparative study of cell-free nucleic acids from human urine.
Bryzgunova OE; Skvortsova TE; Kolesnikova EV; Starikov AV; Rykova EY; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2006 Sep; 1075():334-40. PubMed ID: 17108229
[TBL] [Abstract][Full Text] [Related]
2. Methylation-based analysis of circulating DNA for breast tumor screening.
Rykova EY; Tsvetovskaya GA; Sergeeva GI; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():232-5. PubMed ID: 18837953
[TBL] [Abstract][Full Text] [Related]
3. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
4. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
[TBL] [Abstract][Full Text] [Related]
5. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
[TBL] [Abstract][Full Text] [Related]
6. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis.
Chan AK; Chiu RW; Lo YM;
Ann Clin Biochem; 2003 Mar; 40(Pt 2):122-30. PubMed ID: 12662399
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
[TBL] [Abstract][Full Text] [Related]
8. Cell-surface-bound nucleic acids: Free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients.
Laktionov PP; Tamkovich SN; Rykova EY; Bryzgunova OE; Starikov AV; Kuznetsova NP; Vlassov VV
Ann N Y Acad Sci; 2004 Jun; 1022():221-7. PubMed ID: 15251964
[TBL] [Abstract][Full Text] [Related]
9. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
10. Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.
Rykova EY; Laktionov PP; Skvortsova TE; Starikov AV; Kuznetsova NP; Vlassov VV
Ann N Y Acad Sci; 2004 Jun; 1022():217-20. PubMed ID: 15251963
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
12. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.
Wang Y; Yu Z; Wang T; Zhang J; Hong L; Chen L
Lung Cancer; 2007 May; 56(2):289-94. PubMed ID: 17267069
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
Kioulafa M; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2009 Jul; 42(10-11):970-5. PubMed ID: 19374895
[TBL] [Abstract][Full Text] [Related]
16. Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.
Roos PH; Jakubowski N
Bioanalysis; 2010 Feb; 2(2):295-309. PubMed ID: 21083311
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic developments involving cell-free (circulating) nucleic acids.
Tong YK; Lo YM
Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
[TBL] [Abstract][Full Text] [Related]
19. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
Fleischhacker M; Schmidt B
Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O
Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
